Rhythm Pharmaceuticals
RYTM
RYTM
203 hedge funds and large institutions have $3.63B invested in Rhythm Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
2% more capital invested
Capital invested by funds: $3.55B → $3.63B (+$88M)
5.12% less ownership
Funds ownership: 110.75% → 105.63% (-5.1%)
Holders
203
Holding in Top 10
11
Calls
$26.8M
Puts
$1.76M
Top Buyers
| 1 | +$34.8M | |
| 2 | +$16M | |
| 3 | +$10.2M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.94M |
| 5 |
SC
Stempoint Capital
New York
|
+$9.33M |
Top Sellers
| 1 | -$116M | |
| 2 | -$58.2M | |
| 3 | -$36.1M | |
| 4 |
CC
Commodore Capital
New York
|
-$34.1M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$30.6M |